Company Presentation

At Stämm we develop accessible, plug-and-play manufacture solutions, allowing an automatized, continuous, and more efficient production of biologics and cell therapies while managing media conditions. We are reinventing biomanufacturing by providing an alternative to the known biomass production.
We’ve developed the first bioreactor of continuous production for mAbs and CGT leveraging microfluidics for improving the cell conditions and 3D printing for adaptability.